What is Lifecore Biomedical, Inc.'s earnings yield?

Lifecore Biomedical, Inc. (LFCR) reported earnings yield of -14.9% in Q1 2025.

What is the long-term trend for Lifecore Biomedical, Inc.'s earnings yield?

Over 3 years (2021 to 2025), Lifecore Biomedical, Inc.'s earnings yield has grown at a 17.7% compound annual growth rate (CAGR), from -9.2% to -14.9%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

Lifecore Biomedical, Inc. LFCR Earnings yield

Earnings yield at other companies

Baxter InternationalBAX

-12.7%-19.1pp

Thermo Fisher ScientificTMO

3.8%+0.3pp

ADMA BiologicsADMA

7.7%+3.3pp

Medpace Holdings, Inc.MEDP

3.4%-1.1pp

Biodesix, Inc.BDSX

-22.4%-7.4pp

ClearPoint NeuroCLPT

-10.8%+25.3pp

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

net income/market cap=-14.9%

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s earnings yield?: Lifecore Biomedical, Inc. (LFCR) reported earnings yield of -14.9% in Q1 2025.
What is the long-term trend for Lifecore Biomedical, Inc.'s earnings yield?: Over 3 years (2021 to 2025), Lifecore Biomedical, Inc.'s earnings yield has grown at a 17.7% compound annual growth rate (CAGR), from -9.2% to -14.9%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.